Drugs like semaglutide (Wegovy), tirzepatide (Zepound), liraglutide (Saxenda), and orforglipron (Foundayo) mimic the hormones that help regulate appetite and blood sugar, which slows digestion, increases fullness, and reduces hunger
The companies will initially commence four development programs for potential small-molecule therapies directed to one or more select GPCR targets, including GLP-1, GIP, and glucagon receptors
Broader endocrine effects, including mild ACTH stimulation, have been observed in experimental settings due to ghrelin receptor cross-talk within hypothalamic networks
It's essential to approach anecdotal evidence with caution, recognizing the individual variability in treatment outcomes
Potassium replacement therapy should be administered if necessary.[12][15] Patients with pernicious anemia are three times more likely to have gastric carcinoma compared to general population